We are live on ! Find out more
RAD

Rite Aid Corporation

Delisted

RAD was delisted on the 13th of October, 2023.

388 hedge funds and large institutions have $4.45B invested in Rite Aid Corporation in 2014 Q4 according to their latest regulatory filings, with 103 funds opening new positions, 121 increasing their positions, 109 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 28 (+6)

81% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 57

53% more capital invested

Capital invested by funds: $2.9B → $4.45B (+$1.55B)

11% more repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 109

10% more funds holding

Funds holding: 352388 (+36)

5% less call options, than puts

Call options by funds: $82.3M | Put options by funds: $86.9M

Holders
388
Holders Change
+36
Holders Change %
+10.23%
% of All Funds
10.35%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
103
Increased
121
Reduced
109
Closed
57
Calls
$82.3M
Puts
$86.9M
Net Calls
-$4.54M
Net Calls Change
+$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$828M +$35.4M +318,488 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$478M +$12.3M +110,465 +4%
JP Morgan Chase
3
JP Morgan Chase
New York
$317M +$649K +5,849 +0.3%
BIT
4
BlackRock Institutional Trust
California
$173M +$838K +7,550 +0.7%
Boston Partners
5
Boston Partners
Massachusetts
$106M +$13.2M +118,500 +20%
Millennium Management
6
Millennium Management
New York
$105M +$46.4M +417,569 +148%
State Street
7
State Street
Massachusetts
$102M +$8.98M +80,932 +14%
Morgan Stanley
8
Morgan Stanley
New York
$83.6M +$12M +107,682 +24%
AQR Capital Management
9
AQR Capital Management
Connecticut
$67.2M +$13.7M +123,461 +38%
Arrowstreet Capital
10
Arrowstreet Capital
Massachusetts
$63.3M +$4.59M +41,305 +11%
Norges Bank
11
Norges Bank
Norway
$57.2M -$2.74M -24,706 -6%
BFA
12
BlackRock Fund Advisors
California
$56.7M +$3.06M +27,525 +8%
VAM
13
Visium Asset Management
New York
$56.2M -$6.57M -59,207 -14%
UBS AM
14
UBS AM
Illinois
$55.6M +$11.3M +101,756 +38%
Invesco
15
Invesco
Georgia
$53.4M +$34.4M +309,673 +686%
PCM
16
PAR Capital Management
Massachusetts
$51.5M +$10.2M +92,296 +37%
O
17
OppenheimerFunds
New York
$49.8M +$3.55M +31,958 +11%
Two Sigma Investments
18
Two Sigma Investments
New York
$49.4M +$17.8M +160,247 +95%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$47.2M +$2.91M +26,245 +9%
RG
20
Redmile Group
California
$45.4M +$4.32M +38,901 +15%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$44.2M -$3.37M -30,331 -9%
VNIM
22
Vaughan Nelson Investment Management
Texas
$39.6M +$29.2M +263,341 New
HCM
23
Highbridge Capital Management
New York
$39.6M +$15.8M +142,013 +117%
BCM
24
Brigade Capital Management
New York
$37.6M
TCIM
25
TIAA CREF Investment Management
New York
$36.3M +$161K +1,448 +0.6%

RAD Hedge Fund Activity: Q4 2014 in Review

388 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Rite Aid Corporation (RAD) for Q4 2014, worth a combined $4.45B — up 53% from $2.9B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new RAD positions and 57 closed out — a net gain of 46 holders — while 121 added to existing stakes and 109 trimmed.

The largest buyer was Millennium Management, adding an estimated $46.4M. The largest seller was PFM Health Sciences, cutting an estimated $103M.

  • 388 institutional investors held Rite Aid Corporation (RAD) as of Q4 2014, up from 352 in Q3 2014.
  • Funds reported $4.45B of Rite Aid Corporation stock for Q4 2014, up 53% quarter-over-quarter.
  • 103 funds opened new Rite Aid Corporation positions in Q4 2014 and 57 closed out, a net change of +46 holders.
  • The largest Rite Aid Corporation buyer in Q4 2014 was Millennium Management, an estimated $46.4M added.
  • The largest Rite Aid Corporation seller in Q4 2014 was PFM Health Sciences, an estimated $103M sold.

Based on aggregated 13F filings for Q4 2014.